BN GLOBAL FUND RESEARCH
SBI Healthcare Opportunities Fund - Regular Plan - Growth
SBI Mutual Fund · Sectoral/ Thematic · Regular Plan · Growth
NAV PERFORMANCE
Growth over time
Month-end NAV history supplied for the selected scheme.
INVESTMENT ILLUSTRATION
SIP & lump-sum calculator
Illustration for SBI Healthcare Opportunities Fund - Regular Plan - Growth uses the closest available historical return for the selected period. It is not a forecast or recommendation; actual returns will vary.
RETURN COMPARISON
Historical returns
Regular Plan · Growth returns as at 20-11-2026. Returns above one year are annualised. Shorter periods: 1 week 0.57%, 1 month 12.88%, 3 months 5.12%, 6 months 16.49% .
PORTFOLIO
What the fund holds
SBI Mutual Fund’s portfolio disclosure for Oct 2026 · 37 holdings · 97.1% in equity
Top 10 holdings
| Holding | Sector | % of fund |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.55% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 8.38% |
| Max Healthcare Institute Ltd. | Healthcare Services | 4.96% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | 4.95% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 4.87% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 4.76% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 4.36% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 4.11% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.10% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.06% |
Sectors
- Pharmaceuticals & Biotechnology61.75%
- Healthcare Services29.38%
- Chemicals & Petrochemicals4.39%
- Healthcare Equipment & Supplies1.53%
RISK
SEBI risk-o-meter
Rated Very High, level 6 of 6, by SBI Mutual Fund (as of 31 Oct 2026).
The risk-o-meter is the fund house’s own rating under SEBI rules, from Low to Very High. It can change from month to month.
Figures as of 20 Nov 2026 (NAV history to 15 Oct 2026). If an update is delayed, the last figures received are shown until new data arrives.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance does not guarantee future returns. Scheme information is date-stamped; availability and NRI eligibility must be confirmed before investing. BN Global Private Office is an AMFI-registered mutual fund distributor (ARN-OD122699).